Estrella Immunopharma, Inc. Common Stock (ESLA)
search
Earnings reactions
How ESLA moved on each past earnings report.
Up
Down
Earnings Impact
Estrella Immunopharma, Inc. Common Stock (ESLA) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
Historical Earnings Statistics
Estrella Immunopharma, Inc. Common Stock (ESLA) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
event
Earnings Count
0
Total earnings in dataset
trending_up
Avg Abs. Movement
±0.00%
Avg % price change on earnings
account_balance
View all 8 →
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
8
Funds holding
$163105
Total value held
Buying
5 added · 0 reduced
Blackrock, Inc.
$54114
+30.44%
State Street Corp
$44982
Held
Northern Trust Corp
$36255
+77.64%
Us Bancorp \De\
$20800
+18.32%
Citigroup Inc
$3900
Held
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260908 | open_in_new SEC.gov |
| 4 | 20260826 | open_in_new SEC.gov |
| 4 | 20260825 | open_in_new SEC.gov |
| 8-K | 20260821 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| 10-Q | 20260813 | open_in_new SEC.gov |
| 8-K | 20260630 | open_in_new SEC.gov |
| DEF 14A | 20260527 | open_in_new SEC.gov |
| 10-Q | 20260518 | open_in_new SEC.gov |
| NT 10-Q | 20260518 | open_in_new SEC.gov |